Bierón K - Search Results

1

beta-Pyridylcarbinol (Ronicol) releases a prostacyclin-like substance into arterial blood of patients with arteriosclerosis obliterans.

Dembińska-Kieć A, Korbut R, Bierón K, Kostka-Trabka E, Gryglewski RJ. Dembińska-Kieć A, et al. Among authors: bieron k. Pharmacol Res Commun. 1983 Apr;15(4):377-85. doi: 10.1016/s0031-6989(83)80047-2. Pharmacol Res Commun. 1983. PMID: 6346344

2

Effect of prostacyclin (PGI2) on platelets and fibrinolytic activity in patients with arteriosclerosis obliterans.

Dembińska-Kieć A, Kostka-Trabka E, Zumda A, Byrska-Danek A, Bierón K, Grodzińska L, Kedzior A, Zelazny T. Dembińska-Kieć A, et al. Among authors: bieron k. Pharmacol Res Commun. 1982 Jun;14(6):485-98. doi: 10.1016/s0031-6989(82)80039-8. Pharmacol Res Commun. 1982. PMID: 6750655 No abstract available.

3

Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action.

Kostka-Trabkowa E, Dembińska-Kieć A, Grodzińska L, Bieroń K, Gryglewski RJ. Kostka-Trabkowa E, et al. Among authors: bieron k. Curr Med Res Opin. 1985;9(6):407-15. doi: 10.1185/03007998509109612. Curr Med Res Opin. 1985. PMID: 3886306 Clinical Trial.

4

Clinical use of prostacyclin (PGI2) in ischaemic stroke.

Gryglewski RJ, Nowak S, Kostka-Trabka E, Bieroń K, Dembińska-Kieć A, Błaszczyk B, Kuśmiderski J, Markowska E, Szmatoła S. Gryglewski RJ, et al. Among authors: bieron k. Pharmacol Res Commun. 1982 Oct;14(9):879-908. doi: 10.1016/s0031-6989(82)80012-x. Pharmacol Res Commun. 1982. PMID: 6757974 No abstract available.

5

Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with peripheral arterial disease.

Bieroń K, Grodzińska L, Kostka-Trabka E, Gryglewski RJ. Bieroń K, et al. Wien Klin Wochenschr. 1993;105(1):7-11. Wien Klin Wochenschr. 1993. PMID: 8438599 Clinical Trial.

6

Interaction between prostacyclin and molsidomine in blood cells and plasma.

Gryglewski RJ, Bieroń K, Dembińska-Kieć A, Kostka-Trabka E, Zembowicz A. Gryglewski RJ, et al. Among authors: bieron k. Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:655-8. Adv Prostaglandin Thromboxane Leukot Res. 1991. PMID: 1825393 No abstract available.

7

[Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans].

Dembińska-Kieć A, Kostka-Trabka E, Grodzińska L, Bieroń K, Kedzior A, Basista M, Zmuda A, Trabka E, Slawiński M, Czarnecka H. Dembińska-Kieć A, et al. Among authors: bieron k. Fortschr Med. 1989 Jul 10;107(20):450-2. Fortschr Med. 1989. PMID: 2767596 German.

8

[Effect of beta-pyridylcarbinol on pulmonary arterial pressure and various indicators of the blood coagulation system in patients with secondary pulmonary hypertension].

Dubiel JP, Cibor E, Bieron K, Zmuda A, Kostka-Trabka E. Dubiel JP, et al. Among authors: bieron k. Kardiol Pol. 1988;31(10):626-32. Kardiol Pol. 1988. PMID: 3253452 Polish. No abstract available.

9

Plasma antioxidant potency and serum copper levels in atherosclerosis.

Dembińska-Kieć A, Zmuda A, Bieroń K, Grodzińska L, Basista M, Kedzior A, Kostka-Trabka E. Dembińska-Kieć A, et al. Among authors: bieron k. Pol J Pharmacol Pharm. 1985 Mar-Apr;37(2):123-32. Pol J Pharmacol Pharm. 1985. PMID: 3900961

10

Treatment of ischaemic stroke with prostacyclin.

Gryglewski RJ, Nowak S, Kostka-Trabka E, Kusmiderski J, Dembinska-Kiec A, Bieron K, Basista M, Blaszczyk B. Gryglewski RJ, et al. Among authors: bieron k. Stroke. 1983 Mar-Apr;14(2):197-202. doi: 10.1161/01.str.14.2.197. Stroke. 1983. PMID: 6340253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page